Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03605875
Other study ID # Pro00076483
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date November 28, 2018
Est. completion date December 13, 2019

Study information

Verified date March 2020
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate a web application tool that hemodialysis patients can use outside of dialysis time to log and prioritize their concerns for the nephrologists. Specifically, the investigators will compare the usability of a web application tool to a structured paper form. The investigators will also use data from semi-structured interviews to better understand the experience and acceptability of the web app among patient participants randomized to the web application and among participating nephrologists.

Primary outcome

-Usability (effectiveness, efficiency, satisfaction)

Secondary outcomes

-Quality of the patient-physician interaction (Communication Assessment Tool (CAT-14))


Description:

Usability is defined as Effectiveness (>70%)

- Number of people submitting a concern/ number of people with opportunity to submit a concern

- Number of concerns entered/number of times concern was satisfactorily addressed

Efficiency

- Proportion of non-completed tasks (<70%)

- The amount of time to complete one concern

Satisfaction

- Semistructured interviews

- Usability survey


Recruitment information / eligibility

Status Completed
Enrollment 77
Est. completion date December 13, 2019
Est. primary completion date December 12, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Chronic in-center hemodialysis patients in Edmonton, Alberta and Winnipeg, Manitoba

- Able to provide consent, understand and read English or have a family member that can do this for them

Exclusion Criteria:

- Planning to change modality within the next year

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Web-App
Cambian IT Health solutions from Surrey BC developed the infrastructure
Paper
Contains similar questions to the Web-App tool

Locations

Country Name City State
Canada Edmonton General Hospital Edmonton Alberta
Canada Royal Alexandra Hospital Edmonton Alberta
Canada University of Alberta Hospital Edmonton Alberta
Canada Seven Oaks General Hospital Winnipeg Manitoba

Sponsors (1)

Lead Sponsor Collaborator
University of Alberta

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness - Number of patients submitting a concern divided by the number of patients Number of patients submitting a concern divided by the number of patients with an opportunity to submit a concern 8 weeks
Primary Effectiveness - Number of concerns entered divided by the number of concerns that were satisfactorily addressed Number of concerns entered divided by the number of concerns that were satisfactorily addressed 8 weeks
Primary Efficiency - The amount of time to complete one concern The amount of time to log a concern in the web app 8 weeks
Primary Satisfaction - Usability survey Usability survey Defined as greater than 70% of users who agree or strongly agree with the statement on the usability survey. Ranked on a 5 -point Likert scale 8 weeks
Secondary Communication Assessment Tool Items rated from 1 (poor) to 5 (excellent). Published at Makoul et al. Patient Educ Couns 2007 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04892745 - Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance
Not yet recruiting NCT04925674 - Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. Phase 1
Active, not recruiting NCT03183245 - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Phase 3
Completed NCT03365635 - Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C Phase 4
Withdrawn NCT02904343 - Evaluation of Domestic Hemodialysis Machine: A Multi-center Clinical Study N/A
Withdrawn NCT01855334 - L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD Phase 4
Completed NCT01700465 - Estimating and Predicting Hemodynamic Changes During Hemodialysis N/A
Recruiting NCT01195519 - The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis N/A
Completed NCT00737672 - GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis Phase 3
Completed NCT00527774 - Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients N/A
Completed NCT00942253 - Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS) Phase 2
Completed NCT00850252 - Use of a Lifeline Graft in the A-V Shunt Model Phase 1/Phase 2
Completed NCT00224081 - DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) Phase 4
Completed NCT00776750 - Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients Phase 4
Recruiting NCT06351007 - Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK) N/A
Withdrawn NCT03664141 - Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) Phase 3
Completed NCT03909698 - Antibiotic Dosing in Patients on Intermittent Hemodialysis
Recruiting NCT03311321 - Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients N/A
Recruiting NCT06098924 - HD Patients' Depression and Happiness
Recruiting NCT03419923 - Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage N/A